Reyon Pharmaceutical Co Ltd (102460) — Long-term Investment Intensity
Reyon Pharmaceutical Co Ltd (102460) has a Long-term Investment Intensity of 7.6% as of December 2019. Long-term investments of ₩20.81 Billion represent 7.6% of total assets of ₩274.48 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 102460 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Reyon Pharmaceutical Co Ltd Long-term Investment Intensity (2008–2019)
This chart shows how Reyon Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2008 to 2019. As of December 2019, the intensity stands at 7.6%, reflecting long-term investments of ₩20.81 Billion against total assets of ₩274.48 Billion KRW. For the complete balance sheet picture, see 102460 asset base.
Annual Long-term Investment Intensity for Reyon Pharmaceutical Co Ltd (2008–2019)
The table below presents the year-by-year Long-term Investment Intensity for Reyon Pharmaceutical Co Ltd from 2008 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Reyon Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 7.6% | ₩20.81 Billion | ₩274.48 Billion | ▲ +2.5 pp |
| 2018 | 5.0% | ₩15.29 Billion | ₩303.17 Billion | ▼ -30.2 pp |
| 2017 | 35.3% | ₩102.63 Billion | ₩290.84 Billion | ▲ +2.8 pp |
| 2016 | 32.4% | ₩67.98 Billion | ₩209.54 Billion | ▲ +23.1 pp |
| 2009 | 9.4% | ₩7.69 Billion | ₩81.91 Billion | ▲ +2.8 pp |
| 2008 | 6.6% | ₩4.30 Billion | ₩65.27 Billion | — |